Favorable changes in the survival of patients with cancers of digestive organs – Poland, 2000–2019

Author:

Caetano dos Santos Florentino Luciano1,Michalek Irmina Maria1,Wojciechowska Urszula1,Didkowska Joanna1

Affiliation:

1. Polish National Cancer Registry, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Abstract

Objective This study aimed to estimate cancer survival in Poland in 2000–2019 for malignant neoplasms of digestive organs, namely for cancer of the esophagus, stomach, small intestine, colorectum, anus, liver and intrahepatic bile ducts, gallbladder, other and unspecified parts of the biliary tract and pancreas. Methods Data were obtained from the Polish National Cancer Registry and age-standardized 5- and 10-year net survival was estimated. Results Overall, 534 872 cases were included in the study, reflecting a total of 3 178 934 years of life lost within the 2 decades of observation. Colorectal cancer represented both the highest 5-year and 10-year age-standardized net survival (5-year net survival: 53.0%, 95% confidence interval, 52.8–53.3%; 10-year net survival: 48.6%, 48.2–48.9%). Between 2000–2004 and 2015–2019, the highest statistically significant increase in age-standardized 5-year survival was noted for the small intestine at +18.3 percentual points (P < 0.001). The male-female incidence ratio disparity was the highest for esophageal (4:1) and anus and gallbladder cancer (1:2). The highest standardized mortality ratios were observed in esophageal and pancreatic cancer (23.9, 23.5–24.2 and 26.4, 26.2–26.6, respectively). Overall, death hazard ratios were lower for women (hazard ratio = 0.89, 0.88–0.89, P < 0.001). Conclusion In most cancers, there were statistically significant differences between sexes for all studied metrics. In the last 2 decades, survival for digestive organ cancers has increased considerably. Special attention should be given to liver, esophagus, pancreatic cancer survival and the disparities between sexes.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference26 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Sung;CA Cancer J Clin,2021

2. International variation in oesophageal and gastric cancer survival 2012–2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study).;Arnold;Gut,2022

3. Global burden of 5 major types of gastrointestinal cancer.;Arnold;Gastroenterology,2020

4. Cancer statistics for the year 2020: an overview.;Ferlay;Int J Cancer,2021

5. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.;Kocarnik;JAMA Oncol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3